These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 37437517)

  • 21. Platelet Contributions to Myocardial Ischemia/Reperfusion Injury.
    Schanze N; Bode C; Duerschmied D
    Front Immunol; 2019; 10():1260. PubMed ID: 31244834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.
    Bellis A; Mauro C; Barbato E; Di Gioia G; Sorriento D; Trimarco B; Morisco C
    Cells; 2020 Sep; 9(9):. PubMed ID: 32967374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury.
    Deng RM; Zhou J
    Int Immunopharmacol; 2023 Oct; 123():110714. PubMed ID: 37523969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelets in Myocardial Ischemia/Reperfusion Injury.
    Schanze N; Hamad MA; Nührenberg TG; Bode C; Duerschmied D
    Hamostaseologie; 2023 Apr; 43(2):110-121. PubMed ID: 35913081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in potential targets for myocardial ischemia reperfusion injury: Role of macrophages.
    Zhuang Q; Li M; Hu D; Li J
    Mol Immunol; 2024 May; 169():1-9. PubMed ID: 38447462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium.
    Gawaz M
    Cardiovasc Res; 2004 Feb; 61(3):498-511. PubMed ID: 14962480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review.
    Liu C; Li Z; Li B; Liu W; Zhang S; Qiu K; Zhu W
    PeerJ; 2023; 11():e14952. PubMed ID: 36935924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
    Quintana M; Kahan T; Hjemdahl P
    Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of NF-κB in Myocardial Ischemia/Reperfusion Injury.
    Dong P; Liu K; Han H
    Curr Protein Pept Sci; 2022; 23(8):535-547. PubMed ID: 35980051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvascular thrombosis: an exciting but elusive therapeutic target in reperfused acute myocardial infarction.
    Barrabés JA; Inserte J; Agulló L; Alonso A; Mirabet M; Garcia-Dorado D
    Cardiovasc Hematol Disord Drug Targets; 2010 Dec; 10(4):273-83. PubMed ID: 21067511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research Progress of Chinese Medicine in the Treatment of Myocardial Ischemia-Reperfusion Injury.
    Dong L; Shen Z; Chi H; Wang Y; Shi Z; Fang H; Yang Y; Rong J
    Am J Chin Med; 2023; 51(1):1-17. PubMed ID: 36437553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of non‑coding RNAs in the pathogenesis of myocardial ischemia/reperfusion injury (Review).
    Li Q; Li Z; Fan Z; Yang Y; Lu C
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review).
    He J; Liu D; Zhao L; Zhou D; Rong J; Zhang L; Xia Z
    Exp Ther Med; 2022 Jun; 23(6):430. PubMed ID: 35607376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review.
    Xing N; Long XT; Zhang HJ; Fu LD; Huang JY; Chaurembo AI; Chanda F; Xu YJ; Shu C; Lin KX; Yang K; Lin HB
    Front Pharmacol; 2022; 13():1055248. PubMed ID: 36561346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Regulatory Role of Non-coding RNA in Autophagy in Myocardial Ischemia-Reperfusion Injury.
    Wang D; Niu Z; Wang X
    Front Pharmacol; 2022; 13():822669. PubMed ID: 35370737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purinergic signaling in myocardial ischemia-reperfusion injury.
    Zhuang Y; Yu ML; Lu SF
    Purinergic Signal; 2023 Mar; 19(1):229-243. PubMed ID: 35254594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research Progress on The Mechanism and Treatment of Inflammatory Response in Myocardial Ischemia-Reperfusion Injury.
    Zhang D; Wu H; Liu D; Li YZ; Zhou G
    Heart Surg Forum; 2022 Jun; 25(3):E462-E468. PubMed ID: 35787748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broadening horizons: The role of ferroptosis in myocardial ischemia-reperfusion injury.
    Zhao K; Chen X; Bian Y; Zhou Z; Wei X; Zhang J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2269-2286. PubMed ID: 37119287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of Nrf2 in myocardial ischemia and reperfusion injury.
    Shen Y; Liu X; Shi J; Wu X
    Int J Biol Macromol; 2019 Mar; 125():496-502. PubMed ID: 30468811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.